PSO-NET: Development of an Automated Psoriasis Assessment System Using Attention-Based Interpretable Deep Neural Networks
Psoriasis is a chronic skin condition that requires long-term treatment and monitoring. Although, the Psoriasis Area and Severity Index (PASI) is utilized as a standard measurement to assess psoriasis severity in clinical trials, it has many draw-backs such as (1) patient burden for in-person clinic visits for assessment of psoriasis, (2) time required for investigator scoring and (3) variability of inter-and intra-rater scoring. To address these drawbacks, we propose a novel and inter-pretable deep learning architecture called PSO-Net, which maps digital images from different anatomical regions to derive attention-based scores. Regional scores are further combined to estimate an absolute PASI score. Moreover, we devise a novel regression activation map for interpretability through ranking attention scores. Using this approach, we achieved inter-class correlation scores of 82.2% [95% CI: 77- 87%] and 87.8% [95% CI: 84–91%] with two different clinician raters, respectively.
Authors
- Molly V. Lucas (ORCID: https://orcid.org/0000-0001-7824-2219)
- Sophia C. Kamran (ORCID: https://orcid.org/0000-0001-9283-6515)
- Gabriela Oana Cula
- Atman P. Shah (ORCID: https://orcid.org/0000-0002-7288-2300)
- Brendon Lutnick (ORCID: https://orcid.org/0000-0001-7360-3302)
- Steven Fakharzadeh
- Lloyd Miller (ORCID: https://orcid.org/0000-0002-8332-2210)
- Stephen Yip (ORCID: https://orcid.org/0000-0002-8514-9861)
- Chaitanya Parmar
- Kristopher Standish
- Basudha Pal
- David Apfel
Publication Details
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1109/isbi60581.2025.10980765
- Citations
- 1
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.50